PE20010322A1 - Polimorfos de un diclorhidrato cristalino de azobiciclo [2.2.2]oct-3-ilamina y sus composiciones farmaceuticas - Google Patents
Polimorfos de un diclorhidrato cristalino de azobiciclo [2.2.2]oct-3-ilamina y sus composiciones farmaceuticasInfo
- Publication number
- PE20010322A1 PE20010322A1 PE2000000613A PE0006132000A PE20010322A1 PE 20010322 A1 PE20010322 A1 PE 20010322A1 PE 2000000613 A PE2000000613 A PE 2000000613A PE 0006132000 A PE0006132000 A PE 0006132000A PE 20010322 A1 PE20010322 A1 PE 20010322A1
- Authority
- PE
- Peru
- Prior art keywords
- dichlorhydrate
- azobicycle
- polymorphes
- polymorph
- hygroscopic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE A POLIMORFOS DEL DICLORHIDRATO DE (2-BENCIDRIL-1-AZOBICICLO[2.2.2]OCTIL-3-IL)-(5-ISOPROPIL-2-METOXIBENCIL)AMINA DE FORMULA I, DE PREFERENCIA: a) UNA FORMA ANHIDRA DEL DICLORHIDRATO HIGROSCOPICO QUE SE PRESENTAN EN FORMA DE BASTONCILLOS CON UN TAMANO DE PARTICULA DE 5µm A 30µm, QUE SE CARACTERIZA POR SU TERMOGRAMA DE CALORIMETRIA DIFERENCIAL; b)UN POLIMORFO DEL DICLORHIDRATO DIHIDRATADO NO HIGROSCOPICO (FORMA I) QUE SE CARACTERIZA POR SU PATRON DE DIFRACCION DE RAYOS X, UNA SOLUBILIDAD DE 640 mg/ml A 1160 mg/ml, TERMOGRAMA DE CALORIMETRIA DIFERENCIAL, QUE SE PRESENTA EN FORMA DE ESCAMAS CON UN TAMANO DE 30 µm A 60 µm; c)POLIMORFO DE DICLORHIDRATO DIHIDRATO NO HIGROSCOPICO (FORMA II), QUE SE CARACTERIZA POR SU PATRON DE DIFRACION DE RAYOS X, CON UNA SOLUBILIDAD DE 390mg/ml A 400mg/ml, QUE SE PRESENTA EN FORMA DE ESCAMAS CON UN TAMANO DE 15µm A 25µm. TAMBIEN SE REFIERE A PROCEDIMIENTOS PARA LA PREPARACION DE LAS FORMAS I Y II. EL POLIMORFO ES UN ANTAGONISTA DEL RECEPTOR NK-1 Y ANTAGONISTA DE LA SUSTANCIA P Y PUEDE SER UTIL PARA EL TRATAMIENTO DE LA EMESIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14023399P | 1999-06-22 | 1999-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010322A1 true PE20010322A1 (es) | 2001-03-14 |
Family
ID=22490317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000613A PE20010322A1 (es) | 1999-06-22 | 2000-06-20 | Polimorfos de un diclorhidrato cristalino de azobiciclo [2.2.2]oct-3-ilamina y sus composiciones farmaceuticas |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6262067B1 (es) |
| EP (1) | EP1187834A1 (es) |
| JP (1) | JP2003502425A (es) |
| KR (1) | KR20020030280A (es) |
| CN (1) | CN1390216A (es) |
| AP (1) | AP2001002367A0 (es) |
| AR (1) | AR024411A1 (es) |
| AU (1) | AU767336B2 (es) |
| BG (1) | BG106205A (es) |
| BR (1) | BR0011835A (es) |
| CA (1) | CA2375265A1 (es) |
| CO (1) | CO5190663A1 (es) |
| CZ (1) | CZ20014458A3 (es) |
| DZ (1) | DZ3055A1 (es) |
| EA (1) | EA004264B1 (es) |
| EC (1) | ECSP003538A (es) |
| EE (1) | EE200100698A (es) |
| HR (1) | HRP20010920A2 (es) |
| HU (1) | HUP0201694A3 (es) |
| IL (1) | IL146410A0 (es) |
| IS (1) | IS6161A (es) |
| MA (1) | MA26744A1 (es) |
| MX (1) | MXPA02000033A (es) |
| NO (1) | NO20016187D0 (es) |
| NZ (1) | NZ515348A (es) |
| OA (1) | OA11952A (es) |
| PA (1) | PA8496701A1 (es) |
| PE (1) | PE20010322A1 (es) |
| PL (1) | PL352899A1 (es) |
| SK (1) | SK18672001A3 (es) |
| TN (1) | TNSN00137A1 (es) |
| TR (1) | TR200103688T2 (es) |
| UY (1) | UY26211A1 (es) |
| WO (1) | WO2000078759A1 (es) |
| ZA (1) | ZA200110387B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387925B1 (en) * | 1999-06-01 | 2002-05-14 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
| US6939873B2 (en) | 2000-07-26 | 2005-09-06 | Taro Pharmaceuticals Industries Limited | Non-sedating barbituric acid derivatives |
| US6756379B2 (en) * | 2001-07-26 | 2004-06-29 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbiturate compounds as neuroprotective agents |
| US7683071B2 (en) * | 2000-07-26 | 2010-03-23 | Taro Pharmaceuticals Industries Ltd. | Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid |
| EP1551846A1 (en) * | 2002-10-04 | 2005-07-13 | Merck Sharp & Dohme Ltd. | Azabicyclic spiroether derivatives as receptor antagonists |
| PT1569627E (pt) | 2002-12-11 | 2009-01-20 | Taro Pharma Ind | Método de tratamento de doenças do movimento utilizando derivados do ácido barbitúrico |
| CA2572797A1 (en) * | 2004-07-02 | 2006-01-12 | Daniella Gutman | A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
| EP2081576A4 (en) * | 2006-11-14 | 2010-06-30 | Taro Pharmaceuticals North Ame | METHOD FOR IMPROVING BIOAVAILABILITY FOR NON-EDMING BARBITURATES |
| UA102128C2 (en) * | 2008-12-05 | 2013-06-10 | Х. Луннбек А/С | Nalmefene hydrochloride dihydrate |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
| SK390692A3 (en) * | 1991-05-31 | 1998-02-04 | Pfizer | Quinuclidine derivatives, preparation method thereof and use |
| ATE147385T1 (de) * | 1992-11-12 | 1997-01-15 | Pfizer | Chinuclidin derivat als substanz p antagonist |
| US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
-
2000
- 2000-05-04 US US09/564,528 patent/US6262067B1/en not_active Expired - Fee Related
- 2000-06-06 TR TR2001/03688T patent/TR200103688T2/xx unknown
- 2000-06-06 CN CN00809305A patent/CN1390216A/zh active Pending
- 2000-06-06 PL PL00352899A patent/PL352899A1/xx not_active Application Discontinuation
- 2000-06-06 AP APAP/P/2001/002367A patent/AP2001002367A0/en unknown
- 2000-06-06 EA EA200101179A patent/EA004264B1/ru not_active IP Right Cessation
- 2000-06-06 MX MXPA02000033A patent/MXPA02000033A/es unknown
- 2000-06-06 EP EP00929745A patent/EP1187834A1/en not_active Withdrawn
- 2000-06-06 EE EEP200100698A patent/EE200100698A/xx unknown
- 2000-06-06 PA PA20008496701A patent/PA8496701A1/es unknown
- 2000-06-06 JP JP2001504925A patent/JP2003502425A/ja active Pending
- 2000-06-06 NZ NZ515348A patent/NZ515348A/en unknown
- 2000-06-06 KR KR1020017016407A patent/KR20020030280A/ko not_active Application Discontinuation
- 2000-06-06 BR BR0011835-4A patent/BR0011835A/pt not_active IP Right Cessation
- 2000-06-06 AU AU47745/00A patent/AU767336B2/en not_active Ceased
- 2000-06-06 HU HU0201694A patent/HUP0201694A3/hu unknown
- 2000-06-06 SK SK1867-2001A patent/SK18672001A3/sk unknown
- 2000-06-06 CA CA002375265A patent/CA2375265A1/en not_active Abandoned
- 2000-06-06 OA OA1200100314A patent/OA11952A/en unknown
- 2000-06-06 CZ CZ20014458A patent/CZ20014458A3/cs unknown
- 2000-06-06 WO PCT/IB2000/000756 patent/WO2000078759A1/en not_active Application Discontinuation
- 2000-06-06 IL IL14641000A patent/IL146410A0/xx unknown
- 2000-06-13 CO CO00043885A patent/CO5190663A1/es not_active Application Discontinuation
- 2000-06-20 UY UY26211A patent/UY26211A1/es not_active Application Discontinuation
- 2000-06-20 AR ARP000103053A patent/AR024411A1/es not_active Application Discontinuation
- 2000-06-20 PE PE2000000613A patent/PE20010322A1/es not_active Application Discontinuation
- 2000-06-21 MA MA26007A patent/MA26744A1/fr unknown
- 2000-06-21 DZ DZ000113A patent/DZ3055A1/xx active
- 2000-06-21 TN TNTNSN00137A patent/TNSN00137A1/fr unknown
- 2000-06-22 EC EC2000003538A patent/ECSP003538A/es unknown
-
2001
- 2001-11-13 IS IS6161A patent/IS6161A/is unknown
- 2001-12-10 BG BG106205A patent/BG106205A/bg unknown
- 2001-12-11 HR HR20010920A patent/HRP20010920A2/hr not_active Application Discontinuation
- 2001-12-18 NO NO20016187A patent/NO20016187D0/no not_active Application Discontinuation
- 2001-12-19 ZA ZA200110387A patent/ZA200110387B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60017898T2 (de) | Neuartige heterocyclische carboxamidderivate | |
| US6110918A (en) | Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist | |
| BR0212477A (pt) | 7-aza[2.2.1] bicicloheptanos substituìdos para o tratamento de doenças | |
| PE20061319A1 (es) | Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2-3-dihidro-1-benzofurano-2-il]metil}amina | |
| EE200100419A (et) | Tselekoksiibi polümorfsed kristallivormid | |
| BRPI0714880A2 (pt) | inibidores da transcriptase reversa do hiv | |
| WO2000035865A2 (en) | Tubulin-binding agents | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| PE20010322A1 (es) | Polimorfos de un diclorhidrato cristalino de azobiciclo [2.2.2]oct-3-ilamina y sus composiciones farmaceuticas | |
| BR112014003245B1 (pt) | Composto de ácido n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil] acetamida metanossulfônico monohidratado cristalino, método para a sintetização do mesmo, e composição farmacêutica contendo o mesmo | |
| CL2004000769A1 (es) | Compuestos derivados del acido [2-(8,9-dioxo-2,6-diazabiciclo [5,2,o]non-1-(7)-en-2-il) alquil]fosfonico, antagonistas del receptor n-metil-d-aspartato (nmda); procedimiento de preparacion; composicion farmaceutica; y su uso para tratar desordenes va | |
| PT736525E (pt) | Benzonitrilos e fluoretos como agonistas e antagonistas de 5-ht | |
| CR6606A (es) | 5-cloro-3-(4-metanosulfonilfenil)-6-metil[2,3 ]-bipiridinil en forma cristalina pura y proceso para su sintesis | |
| AU2009350978A1 (en) | Lenalidomide salts | |
| GT200000197A (es) | 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6- morfolin-4-il-4-o tolil-piridin-3-il)-isobutiramida. | |
| RU2007136782A (ru) | Ингибирующие вич 2-(4-цианофенил)-6-гидроксиламинопиримидины | |
| JP6116761B2 (ja) | 代謝型グルタミン酸受容体アンタゴニストとしてのエチニル誘導体 | |
| TWI355265B (en) | Hiv protease inhibiting compounds | |
| EP0902018A3 (en) | 2-(Arylphenyl)amino-imidazoline derivatives | |
| AR025779A1 (es) | Forma polimorfica cristalina de eletriptan, composicion farmaceutica que la contiene, uso de la forma y procedimiento de preparacion. | |
| DE69624829T2 (de) | Thienopyrimidinderivate als endothelin antagonisten | |
| ES2251234T3 (es) | Nuevos derivados de pirimidina y proceso para su preparacion. | |
| BG107407A (en) | Novel polymorph v of torasemide | |
| CN100549005C (zh) | 旋光性二氢吡啶衍生物 | |
| PE20010155A1 (es) | Polimorfos de un citrato de azobiciclo [2.2.2]oct-3-ilamina cristalino y sus composiciones farmaceuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |